Tumor Regression Grade (TRG) is a histological assessment used to evaluate the response of a tumor to preoperative therapies such as chemotherapy or radiotherapy. It measures the extent of tumor cell destruction and the degree of fibrosis and inflammation in the treated tumor tissue. TRG is an essential parameter in understanding the effectiveness of therapeutic interventions and predicting patient prognosis.
